California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan.
The settlement in principle accounts for New Jersey-based Amneal's role in fueling the national epidemic of opioid addictions and overdoses, New York and California said in separate statements.
New Jersey-based drug manufacturer Amneal Pharmaceuticals has become the latest company to reach a settlement agreement with ...
The number of U.S. fatal overdoses fell last year. The Centers for Disease Control and Prevention posted the numbers ...
New York state will get a cut of a $270 million multistate settlement with opioid maker Amneal Pharmaceuticals over ...
SACRAMENTO, Calif. — California will soon begin selling its own generic version of Narcan — the drug that can save someone’s life during an opioid overdose — under a deal announced Monday ...
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan SACRAMENTO, Calif. -- California will soon begin selling its own generic version of ...
Find your bookmarks in your Independent Premium section, under my profile Amneal Pharmaceuticals will sell naloxone to California for $24 per pack, or about 40% cheaper than the market rate.
SACRAMENTO — California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the drug that can save someone’s life during an opioid overdose ...
SACRAMENTO, Calif. -- California will soon begin selling its own generic version of Narcan - the drug that can save someone's life during an opioid overdose - under a deal announced Monday by ...